These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 8855941)

  • 1. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments.
    Bini A; Wu D; Schnuer J; Kudryk BJ
    Biochemistry; 1999 Oct; 38(42):13928-36. PubMed ID: 10529239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
    Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
    Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.
    Schönbeck U; Mach F; Libby P
    J Immunol; 1998 Oct; 161(7):3340-6. PubMed ID: 9759850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy.
    Webster L; Chignell AH; Limb GA
    Exp Eye Res; 1999 Jan; 68(1):91-8. PubMed ID: 9986746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of the complete coding sequence of rat fibrinogen B beta chain cDNA: interspecies conservation of fibrin beta 15-42 primary structure.
    Courtney MA; Bunce LA; Neroni LA; Simpson-Haidaris PJ
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):487-96. PubMed ID: 7841303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
    Monea S; Lehti K; Keski-Oja J; Mignatti P
    J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII.
    Hiller O; Lichte A; Oberpichler A; Kocourek A; Tschesche H
    J Biol Chem; 2000 Oct; 275(42):33008-13. PubMed ID: 10930399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line.
    Wu AJ; Lafrenie RM; Park C; Apinhasmit W; Chen ZJ; Birkedal-Hansen H; Yamada KM; Stetler-Stevenson WG; Baum BJ
    J Cell Physiol; 1997 May; 171(2):117-24. PubMed ID: 9130458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of tropoelastin by matrix metalloproteinases--cleavage site specificities and release of matrikines.
    Heinz A; Jung MC; Duca L; Sippl W; Taddese S; Ihling C; Rusciani A; Jahreis G; Weiss AS; Neubert RH; Schmelzer CE
    FEBS J; 2010 Apr; 277(8):1939-56. PubMed ID: 20345904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
    Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Matrix metalloproteinases and their biological functions].
    Solov'eva NI
    Bioorg Khim; 1998 Apr; 24(4):245-55. PubMed ID: 9612566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
    EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.